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High frequency of submicroscopic chromosomal imbalances in patients with syndromic craniosynostosis detected by a combined approach of microsatellite segregation analysis, multiplex ligation-dependent probe amplification and arraybased comparative genome hybridisation ABSTRACT We present the first comprehensive study, to our knowledge, on genomic chromosomal analysis in syndromic craniosynostosis. In total, 45 patients with craniosynostotic disorders were screened with a variety of methods including conventional karyotype, microsatellite segregation analysis, subtelomeric multiplex ligationdependent probe amplification) and whole-genome array-based comparative genome hybridisation. Causative abnormalities were present in 42.2% (19/45) of the samples, and 27.8% (10/36) of the patients with normal conventional karyotype carried submicroscopic imbalances. Our results include a wide variety of imbalances and point to novel chromosomal regions associated with craniosynostosis. The high incidence of pure duplications or trisomies suggests that these are important mechanisms in craniosynostosis, particularly in cases involving the metopic suture.
Craniosynostosis is defined as the premature closure of >1 cranial suture. With an estimated prevalence of 1 in 2000-3000 births, 1 it is an important abnormality in clinical practice. Craniosynostosis comprises a heterogeneous group of birth defects, including isolated forms and syndromic cases, in which genetics play an important role, particularly among the second group. Mutations in seven genes (FGFR1, FGFR2, FGFR3, TWIST1, EFNB1, MSX2 and RAB23) are unequivocally associated with mendelian forms of syndromic craniosynostosis, and explain the aetiology of about 30% of syndromic cases. 2 An additional 16% of syndromic cases have been associated with chromosomal abnormalities in conventional cytogenetics studies 1 . Although in the past 15 years, great efforts have been made to identify genes and pathways associated with the onset of craniosynostosis, many of which have been successful, no genome-wide investigation of chromosomal imbalances in these patients has been published.
The main aims of this study were to investigate if submicroscopic chromosomal rearrangements account for a significant proportion of alterations in syndromic patients with craniosynostosis and to verify if there is a more predominant type of chromosomal imbalance involved. We report our investigation of chromosomal abnormalities in 45 patients with syndromic craniosynostosis, using a combination of conventional cytogenetics analysis, polymorphic microsatellite segregation analysis (PMSA), subtelomeric multiplex ligation-dependent probe amplification (MLPA), and array-based comparative genomic hybridisation (array-CGH).
METHODS
Clinical inclusion was based upon two criteria: (1) patients with syndromic craniosynostosis that did not resemble a well-known monogenic disorder and (2) patients with Saethre-Chotzen syndrome who were negative on mutational screening. All patients with coronal synostosis, including those with Saethre-Chotzen syndrome, were negative for mutations in FGFR1 (p.Pro252Arg), FGFR2 (exons IIIa and IIIc), FGFR3 (p.Pro250Arg) and TWIST1 (coding region and whole gene deletion).
Our sample consisted of 45 patients; synostosis was metopic in 26 (57.8%), coronal in 8 (17.8%), multiple in 7 (15.6%) and sagittal in 4 (8.9%). Clinical data from all patients is available online (supplementary table 1 online).
Chromosomal analyses at ,550 G-band resolution were performed on peripheral blood lymphocytes of all patients. Microdeletions at 9p22-24 and 11q23-24 were investigated using PMSA in patients with metopic synostosis as described previously. 3 Patients with negative results were subsequently screened for subtelomeric imbalances with MLPA kits P036/P036B (MRC-Holland, Amsterdam, The Netherlands; www.mlpa.com). Abnormal results were confirmed with a second reaction kit (P036B or P069; MRC-Holland). Individuals with normal results were screened with array-CGH of ,1 Mb as previously described. 4 
RESULTS AND DISCUSSION
The analysis of G-banded chromosomes in the total sample of 45 patients revealed de novo abnormalities in nine (20.0%) ( 5 and the del(7)(p14p15.1) in patient 8. The deleted chromosomal segment in patient 8 does not overlap with the deletions at 7p21 (TWIST1) and 7p13 commonly associated with craniosysnostosis. Therefore, the band 7p14-p15.1 could represent another important region for suture development. Mosaicism with a normal cell line was detected in two patients (6 and 7) (4.4%). The level of mosaicism in patient 7 was very low, indicating that a nondetected abnormal cell line should be considered as a possible cause of craniosynostosis in a syndromic patient with a normal karyotype.
The 24 patients with metopic synostosis who did not have chromosomal abnormalities at the G-band level were screened by PMSA, and 4 had deletions at 9p or 11q (16.7%) (table 2). Of the remaining 32 patients without detectable chromosomal abnormalities, subtelomeric imbalances were identified by MLPA in 5, but only 4 were considered causative (12.5%) (table 2). Although three of these patients (patients 14, 15 and 16) had deletions involving known microdeletion syndromes, involving 9qter and 1qter, they were not clinically recognised as having these conditions before testing. These findings reinforce the difficulties in the clinical recognition of these syndromes, mainly when additional duplicated segments are involved. Patient 18, bearing a de novo deletion 1p, did not have the facial gestalt of this syndrome. The deleted segment in this patient encompasses a maximum of 88 kb and is ,500 kb distant from the matrix metalloproteinase (MMP)-23 genes (MMP-23A and MMP-23AB), which were found in triplicate in two patients with craniosynostosis with 1p36 rearrangements; these genes have been proposed to be involved in cranial suture development. 6 Although the causality of the 1p deletion in this patient cannot be confirmed, the de novo status of this deletion leads us to speculate whether the uncovering of a recessive mutation in the other allele or the deletion of a regulatory element could contribute to the aetiology of craniosynostosis in this patient.
Patients 14 and 17 have 17qter duplications, an abnormality only once reported in a patient with craniosynostosis. 7 Although the origin and causality of the dup 17qter in patient 14 cannot be confirmed due to lack of parental material, the De novo Unknown FISH, fluorescent in situ hybridisation; MLPA, multiplex ligation-dependent probe amplification; PMSA, polymorphic microsatellite segregation analysis. *PMSA for regions 9p22-24 and 11q23-24 is described elsewhere. 3 MLPA data are based on consistent results with kits P036 and P036B for patients 14 and 15, with kits P036B and P069 for patients 16 and 17 and with kits P036B and P147 for patient 18. {Parental samples were not available, so we cannot exclude the possibility of these alterations being inherited by one healthy parent; however the clinical features are consistent with Deletion 9qter syndrome, indicating that at least the 9qter deletion is causative in this patient. {See supplementary fig 1 online . 1See supplementary table 2 online for PMSA details on patients 15 and 16. " MLPA kit P147 was specifically designed for mapping 1p36 deletions and only detected deletion of probe 2271-L1763 (see supplementary fig 1 online) . The hybridisation site of probe 2271-L1763 in this patient was sequenced and no mutation was detected. Paternity was confirmed by segregation analysis of markers D1S243, D1S468, D1S171 and D1S2845. This probe is described as polymorphic (http://www.mlpa.com/ pages/p036bpag.htm)l. This patient was not included in the group of causative imbalances. Array-based comparative genome hybridisation analysis was also performed for patient 18 (supplementary table 3 online). pure 17q24.2-qter duplication in patient 17 is probably causative of the phenotype because it is de novo and encompasses a 14.8 Mb section to which 276 genes have been mapped (see supplementary fig 1) .
Using array-CGH, we investigated the remaining 28 patients (including patient 18), without chromosomal abnormalities detected by G-band analysis, subtelomeric MLPA or target PMSA, and found 12 alterations (table 3) . Two imbalances were considered causative for the patient's phenotype (6.9%): a duplication at Xq22.3 (patient 19) and a duplication at Xp22.2 (patient 20). Patient 19, a boy with a clinical diagnosis of FG (Opitz-Kaveggia) syndrome has been fully described previously. 8 Patient 20 was a 6-year-old boy with bilateral coronal and metopic synostosis that required corrective surgery. The patient attained the major milestones with a delay, crawling at 12 months and walking unassisted at 24 months. He presented with ocular hypertelorism (outer canthal distance .p97), small and long palpebral fissures, protruding ears, clinodactyly and brachydactyly of the fifth finger on both hands and short stature (2.5th centile). The proband's mother and sister had similar but milder facial features (outer canthal distance between 75th and 97th centile) and brachycephalic head format with no palpable metopic ridging. Short stature was only present in the mother (,2.5th centile) and the fifth finger anomaly was present in both mother and sister. Array-CGH analysis showed that all affected family members carried a duplication of 0.9 Mb at Xp22.2. This duplication was further mapped with X-chromosome tile-path array (supplementary  table 3 ) and may include four known genes: MID1, HCCS, AMELX and ARHGAP6. MLPA using kit P233 showed that the coding region of MID1 was not duplicated in the patients (supplementary fig 1) . We considered this duplication to be probably pathogenic based on the fact that it segregates with the affection in the family, is not reported in the Database of Genomic Variants for the human genome (http://projects.tcag. ca/variation; accessed 17 November 2007), overlaps with a duplication of 7 Mb reported in a family with mental retardation 9 and has never been observed among .500 individuals studied by us (,250 normal and ,250 patients).
In total, 11 alterations found by array-CGH could not be clearly associated with the phenotype, because they were (1) not present in a similarly affected parent or sibling (patients 21 and 29), (2) inherited from a normal parent (patients 18, 24-28) or (3) of unknown origin but overlapping reported segmental duplications or known CNVs (patients 22 and 23). The Xp11.23 deletion in patient 21, described as both pathogenic and polymorphic in individuals with mental retardation, 10 11 was considered non-causative in our patient because it does not segregate with the phenotype in the family. Its clinical significance in the predisposition to mental retardation or craniofacial dysmorphism still needs further studies. 27 .8% (10/36) carried submicroscopic imbalances, showing that submicroscopic chromosomal alterations represent an important causative mechanism in syndromic craniosynostosis. This frequency is higher than the 2-10% rate found in similar studies on mental retardation, [11] [12] [13] reinforcing the suggestion that major dysmorphisms are more frequently associated with chromosomal abnormalities and indicating that, particularly for craniosynostosis, this might be an important mutational mechanism. It is of note that only one submicroscopic imbalance, a deletion 22q11.21, was found in a series of 63 patients with syndromic cleft defects, 14 therefore, submicroscopic imbalances may not be common for all craniofacial abnormalities. Although subtelomeric duplications were suggested to be an infrequent cause of mental retardation (0.5%), 15 13 .9% of our patients had pure segmental duplications or trisomies, suggesting that increased gene dosage could be an important mechanism in craniosynostosis.
Regarding the type of suture involved, 57.8% of patients in our sample had metopic synostosis, 17.8% coronal synostosis, 15.6% multiple synostosis and 8.9% sagittal synostosis. These proportions are possibly not representative of syndromic craniosynostosis, because our sample is biased towards metopic synostosis. However, it is interesting to note that although submicroscopic imbalances were found in 30.8% (8/26) of patients with metopic synostosis, 25% (1/4) of patients with sagittal synostosis and 14.3% (1/7) of patients with multiple synostosis, none of the nine patients with coronal synostosis only had submicroscopic rearrangements, suggesting that this type of imbalance might be rarer in this last subgroup.
The use of target PMSA, subtelomeric MLPA and array-CGH doubled the detection rate of chromosomal imbalances in our sample, and should be considered as a diagnostic strategy for a patient with syndromic craniosynostosis with a normal karyotype result. The use of array-CGH increased the detection rate of chromosomal abnormalities from 37.7% to only 42.2%. Taking into consideration that this is a relatively expensive technique and its analysis is complicated due to the increasing data on polymorphic CNVs in the human genome, its choice of use in the screening strategy of a patient with syndromic craniosynostosis will be dependent on the laboratory setting and funding. The inclusion of target PMSA and subtelomeric MLPA before whole genome screening found eight imbalances in our sample and decreased the number of array-CGH tests needed in 22%, and was therefore an important factor in lowering the costs of the final screening. Had we carried out only subtelomeric MLPA before array-CGH, only one interstitial deletion would have been missed. Therefore, searching for subtelomeric imbalances before whole-genome screening is strongly advised.
In conclusion, submicroscopic chromosomal imbalances accounted for almost 22% of the abnormalities found in our sample of syndromic craniosynostosis, being even more frequent than alterations detected using conventional karyotype testing. Increased gene dosage seems to be an important mutational mechanism in syndromic craniosynostosis.
